Current Issue: 15. 8. 2026, Volume: 39, Issue: 4
In the current issue:
-
IgG4-related disease – treatment with anti-CD20, anti-CD19 antibodies, and other new drugs
Adam Zdeněk et al. -
Strategies for utilizing Ki67 and multigene assays as a window of opportunity in the treatment of HR+/HER2– early breast cancer in clinical practice
Bielčiková Zuzana et al. -
FGFR2 fusion as the key to targeted therapy – a case report with a diagnostic turning point
Pešek Miloš et al.